Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 3,630 | 6,992 | 2,036 | 1,675 |
| Gross Profit | 3,630 | 6,992 | 2,036 | 1,675 |
| Operating Expenses | 38,641 | 33,793 | 31,170 | 31,275 |
| Operating Income | -35,011 | -26,801 | -29,134 | -29,600 |
| Interest Expense | 607 | 791 | 323 | 114 |
| Other Income | 640 | 731 | 31 | 261 |
| Pre-tax Income | -34,978 | -26,861 | -29,426 | -29,453 |
| Income Tax | 40 | 138 | 28 | 32 |
| Net Income Continuous | -35,018 | -26,999 | -29,454 | -29,485 |
| Net Income | $-35,018 | $-26,999 | $-29,454 | $-29,485 |
| EPS Basic Total Ops | -0.88 | -0.82 | -0.94 | -1.06 |
| EPS Basic Continuous Ops | -0.89 | -0.82 | -0.94 | -1.06 |
| EPS Diluted Total Ops | -0.88 | -0.82 | -0.94 | -1.06 |
| EPS Diluted Continuous Ops | -0.89 | -0.82 | -0.94 | -1.06 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -0.82 | -0.47 | N/A |
| EBITDA(a) | $-33,011 | $-24,414 | $-27,584 | $-27,828 |